AAAAAA

   
Results: 1-19 |
Results: 19
Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus
Authors: Pouzet, B Serradeil-Le Gal, C Bouby, N Maffrand, JP Le Fur, G Bankir, L
Citation: B. Pouzet et al., Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus, NEPH DIAL T, 16(4), 2001, pp. 725-734
A nonpeptide vasopressin V-1a receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets
Authors: Grelot, L Girod, V Dapzol, J Maffrand, JP Gal, CSL
Citation: L. Grelot et al., A nonpeptide vasopressin V-1a receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets, FUN CL PHAR, 15(3), 2001, pp. 189-200
Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries
Authors: Anderson, HV McNatt, J Clubb, FJ Herman, M Maffrand, JP DeClerck, F Ahn, C Buja, LM Willerson, JT
Citation: Hv. Anderson et al., Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries, CIRCULATION, 104(19), 2001, pp. 2331-2337
Effect of SR121463, a selective non-peptide vasopressin V-2 receptor antagonist, in a rabbit model of ocular hypertension
Authors: Lacheretz, F Barbier, A Serradeil-Le Gal, C Elena, PP Maffrand, JP Le Fur, G
Citation: F. Lacheretz et al., Effect of SR121463, a selective non-peptide vasopressin V-2 receptor antagonist, in a rabbit model of ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 203-216
Identification and biological activity of the active metabolite of clopidogrel
Authors: Savi, P Pereillo, JM Uzabiaga, MF Combalbert, J Picard, C Maffrand, JP Pascal, M Herbert, JM
Citation: P. Savi et al., Identification and biological activity of the active metabolite of clopidogrel, THROMB HAEM, 84(5), 2000, pp. 891-896
Binding properties of a selective tritiated vasopressin V-2 receptor antagonist, [H-3]-SR 121463
Authors: Serradeil-Le Gal, C Raufaste, D Double-Cazanave, E Guillon, G Garcia, C Pascal, M Maffrand, JP
Citation: C. Serradeil-le Gal et al., Binding properties of a selective tritiated vasopressin V-2 receptor antagonist, [H-3]-SR 121463, KIDNEY INT, 58(4), 2000, pp. 1613-1622
Long-term aquaretic efficacy of a selective nonpeptide V-2-vasopressin receptor antagonist, SR121463, in cirrhotic rats
Authors: Jimenez, W Serradeil-Le Gal, C Ros, J Cano, C Cejudo, P Morales-Ruiz, M Arroyo, V Pascal, M Rivera, F Maffrand, JP Rodes, J
Citation: W. Jimenez et al., Long-term aquaretic efficacy of a selective nonpeptide V-2-vasopressin receptor antagonist, SR121463, in cirrhotic rats, J PHARM EXP, 295(1), 2000, pp. 83-90
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle
Authors: Manara, L Croci, T Aureggi, G Guagnini, F Maffrand, JP Le Fur, G Mukenge, S Ferla, G
Citation: L. Manara et al., Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle, GUT, 47(3), 2000, pp. 337-342
Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes
Authors: Serradeil-Le Gal, C Lafontan, M Raufaste, D Marchand, J Pouzet, B Casellas, P Pascal, M Maffrand, JP Le Fur, G
Citation: C. Serradeil-le Gal et al., Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes, FEBS LETTER, 475(2), 2000, pp. 150-156
Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist
Authors: Herbert, JM Savi, P Maffrand, JP
Citation: Jm. Herbert et al., Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist, EUR H J SUP, 1(A), 1999, pp. A31-A40
The cloned guinea pig neuropeptide Y receptor Y-1 conforms to other mammalian Y-1 receptors
Authors: Berglund, MM Holmberg, SKS Eriksson, H Gedda, K Maffrand, JP Serradeil-Le Gal, C Chhajlani, V Grundemar, L Larhammar, D
Citation: Mm. Berglund et al., The cloned guinea pig neuropeptide Y receptor Y-1 conforms to other mammalian Y-1 receptors, PEPTIDES, 20(9), 1999, pp. 1043-1053
Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist
Authors: Herbert, JM Savi, P Maffrand, JP
Citation: Jm. Herbert et al., Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist, EUR HEART J, 20, 1999, pp. A31-A40
Binding of the non-peptide vasopressin V-1a receptor antagonist SR-49059 in the rat brain: An in vitro and in vivo autoradiographic study
Authors: Tribollet, E Raufaste, D Maffrand, JP
Citation: E. Tribollet et al., Binding of the non-peptide vasopressin V-1a receptor antagonist SR-49059 in the rat brain: An in vitro and in vivo autoradiographic study, NEUROENDOCR, 69(2), 1999, pp. 113-120
The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment
Authors: Bourrie, B Bribes, E Esclangon, M Garcia, L Marchand, J Thomas, C Maffrand, JP Casellas, P
Citation: B. Bourrie et al., The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment, P NAS US, 96(22), 1999, pp. 12855-12859
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies
Authors: Bignon, E Bachy, A Boigegrain, R Brodin, R Cottineau, M Gully, D Herbert, JM Keane, P Labie, C Molimard, JC Olliero, D Oury-Donat, F Petereau, C Prabonnaud, V Rockstroh, MP Schaeffer, P Servant, O Thurneyssen, O Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies, J PHARM EXP, 289(2), 1999, pp. 742-751
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization
Authors: Bignon, E Alonso, R Arnone, M Boigegrain, R Brodin, R Gueudet, C Heaulme, M Keane, P Landi, M Molimard, JC Olliero, D Poncelet, M Seban, E Simiand, J Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization, J PHARM EXP, 289(2), 1999, pp. 752-761
In vitro functional evidence of different neurotensin-receptors modulatingthe motor response of human colonic muscle strips
Authors: Croci, T Aureggi, G Guagnini, F Manara, L Gully, D Le Fur, G Maffrand, JP Mukenge, S Ferla, G Ferrara, P Chalon, P Vita, N
Citation: T. Croci et al., In vitro functional evidence of different neurotensin-receptors modulatingthe motor response of human colonic muscle strips, BR J PHARM, 127(8), 1999, pp. 1922-1928
The non-peptide neuroprotective agent SR 57746A interacts with neurotrophin-3 to induce differentiation in the PC12 cell-line
Authors: Fournier, J Boutot, G Keane, PE Maffrand, JP Le Fur, G Soubrie, P
Citation: J. Fournier et al., The non-peptide neuroprotective agent SR 57746A interacts with neurotrophin-3 to induce differentiation in the PC12 cell-line, J PHARM PHA, 50(3), 1998, pp. 323-327
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum
Authors: Croci, T Manara, L Aureggi, G Guagnini, F Rinaldi-Carmona, M Maffrand, JP Le Fur, G Mukenge, S Ferla, G
Citation: T. Croci et al., In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum, BR J PHARM, 125(7), 1998, pp. 1393-1395
Risultati: 1-19 |